Cite

HARVARD Citation

    Jervis, M. et al. (2022). GLP‐1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin. Diabetes/metabolism research and reviews. 38 (8), p. n/a. [Online]. 
  
Back to record